A Randomized, Open-Label, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Avelumab (MSB0010718C) in Combination With and/or Following Chemotherapy in Patients With Previously Untreated Epithelial Ovarian Cancer
Open Plain Language Summary Result:
Click here